申请人:——
公开号:US20040265847A1
公开(公告)日:2004-12-30
The present invention is directed to methods for treating Alzheimer's Disease by modulating divalent cation, trivalent cation and/or heparin interaction with amyloid precursor protein (APP). In particular, the present invention is directed to methods for treating Alzheimer's Disease by administering to a patient with Alzheimer's Disease a therapeutically effective amount of a zinc binding agent for modulating the interaction of zinc and/or heparin with APP and thereby preventing the aberrant processing of APP.
本发明涉及通过调节二价阳离子、三价阳离子和/或肝素与淀粉样前体蛋白(APP)的相互作用来治疗阿尔茨海默病的方法。特别是,本发明涉及通过向阿尔茨海默病患者施用治疗有效量的锌结合剂治疗阿尔茨海默病的方法,该锌结合剂用于调节锌和/或肝素与APP的相互作用,从而防止APP的异常处理。